Company profile for Transcend Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Transcend Therapeutics, founded in 2021, is a clinical-stage neuroscience company developing rapid-acting treatments for neuropsychiatric disorders. Focused on addressing unmet needs in mental health, we aim to bring effective solutions to patients unserved by current therapies. Our leadership team has contributed to 13 FDA approvals, $3.5B in M&A, and significant value creation in the public biotech space, positioning us to t...
Transcend Therapeutics, founded in 2021, is a clinical-stage neuroscience company developing rapid-acting treatments for neuropsychiatric disorders. Focused on addressing unmet needs in mental health, we aim to bring effective solutions to patients unserved by current therapies. Our leadership team has contributed to 13 FDA approvals, $3.5B in M&A, and significant value creation in the public biotech space, positioning us to transform the future of psychiatric care.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
80 5th Ave, Floor 18 New York, New York, 10011
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/transcend-therapeutics-receives-breakthrough-therapy-designation-for-tsnd-201-methylone-for-the-treatment-of-ptsd-302501928.html

PR NEWSWIRE
11 Jul 2025

https://www.prnewswire.com/news-releases/transcend-therapeutics-announces-primary-endpoint-met-in-impact-1-phase-2-study-of-tsnd-201-in-ptsd-302415138.html

PR NEWSWIRE
31 Mar 2025

https://www.fiercebiotech.com/biotech/budding-psychiatry-biotech-looks-transcend-ptsd-competition-sample-phase-2-data

Max Bayer FIERCE BIOTECH
06 Dec 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty